WHO Home
WHO Health Systems and Services
WHO Medicines
WHO sites
Medicines Documentation home
Search
Titles A-Z
Subjects
Keywords
Series and Periodicals
Publishers
Authors A-Z
Regions
Countries
Index
A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z

P  
Parasite resistance to antimalarial drugs
Partnerships to improve access to treatment
The patient morbidity-standard treatment method
Pattern of stability of common injectable oxytocics
Pharmaceutical development and quality assurance of FDCs
Pharmaceutical markets: structure and performance
Pharmaceutical sector reform in Newly Independent States (NIS)
Pharmaceutical substances, medicinal plant materials and dosage forms
Pharmaceuticals and health sector reform
Pharmaceuticals and the WTO TRIPS Agreement
Pharmaceuticals in the trade related aspects of the Intellectual Property Rights (TRIPS) Agreement
Pharmaceuticals: restrictions in use and availability
Pharmaceuticals with no or low toxicity
Pharmacogenetics and existing therapies
Pharmacological classification with corresponding examples of common stems and their definitions
Pharmacovigilance: detecting and reporting adverse drug reactions
Pharmacovigilance: ensuring the safe use of medicines
The philosophy of intellectual property rights
Planning for activities to promote rational use of drugs
Policy: vital for health systems development
Post-marketing scientific studies, surveillance and dissemination of information
Practical advice on good donation practice
Practical guidelines on pharmaceutical procurement
Practicalities in the organisation of a pharmacovigilance centre
Prescription control and pharmaco-economic assessment
Prevention of cross-contamination and bacterial contamination in production
Prevention of mother to child transmission of HIV
Prices of products for the prevention, diagnosis and treatment of malaria
Primary health care systems
Producing national drug and therapeutic information
Product costs of fixed-dose combination tablets
Product specifications, packaging and labelling requirements
Professional, industry and patients' organizations
Progress in essential drugs and medicines policy
Promoting appropriate drug use
Promoting essential drugs, rational drug use and generics
Promoting science or sales?
A proposed standard international acupuncture nomenclature
Protection and promotion of traditional medicine
Protection of data submitted for the registration of pharmaceuticals
Psychiatric disorders and mental disturbances
Public education in rational drug use
Public health and environmental factors
Public health priorities
Public-private roles in the pharmaceutical sector

 
 Top of page
Q  
Quality and safety: Information for action
Quality assurance in pharmaceutical supply systems
Quality assurance of pharmaceuticals
Quality control - national laboratories
Quality control methods for medicinal plant materials
Quality management in the drug industry: philosophy and essential elements
The quality of antimalarials
Quality of pharmaceuticals in developing countries
Quality systems requirements for national good manufacturing practice inspectorates
Questionnaire for collecting information on drug regulation and the problem of counterfeit drugs
Questionnaire for use in sample collection and investigation of samples

 
 Top of page
R  
Rapid assessment methodology for injection practices research
Rates of adherence to inhaled corticosteroids and other drugs for the prevention of asthma
Rational use: Action at all levels of care
Rational use of drugs
Reduction of import and other taxes for essential medicines, and rational dispensing practices
Reference substances and infrared reference spectra for pharmacopoeial analysis
Reform of health care services in developing countries
Regulation, policies and essential drugs
Regulatory assessment of interchangeable multisource pharmaceutical products
Regulatory experience in industrialized countries
Role of the drug regulatory authority in drug donation
Role of the pharmacist: quality pharmaceutical services
Roles of the pharmacist in Southern and Eastern Africa

 
 Top of page
S  
Safe and appropriate use of injections
Safety and long-term effectiveness of generic fixed-dose formulations
Safety monitoring of medicinal products
Safety of medicines
Sampling procedure for industrially manufactured pharmaceuticals
Scaling up antiretroviral therapy in resource-limited settings
Selected acupuncture points for basic training
Selected Medicines and Diagnostics for People Living with HIV/AIDS
Selecting your P(ersonal) drugs
The selection and use of essential medicines
Selection of medicines to be included in the national formulary
Selection of recommended international nonproprietary names for pharmaceutical substances
Self-medication and its impact on essential drugs schemes in Nepal
The situation of counterfeit drugs
Sources and prices of selected drugs and diagnostics for people living with HIV/AIDS
Specifications for the finished product
Stability experiments on degradable substances
Stability of essential drugs in tropical climates
Standard treatment guidelines (STGs)
Starting materials for pharmaceutical products
Sterile pharmaceutical products
Strategies to increase affordability
Strategies to strengthen effectiveness of drug donations
Strengthening country support to improve access to essential drugs
Structure and financing of a drug regulatory authority
Structure of public and private pharmaceutical prices
Substances resistant to degradation
Supplementary training modules on good manufacturing practice

 
 Top of page
T  
Teacher's guide to good prescribing
Therapeutic efficiency in drug selection and use
Third international training programme in pharmacoeconomics
Tobacco smoking cessation
Tools to investigate the use of medicines
Towards a rapid assessment methodology for injection practices research
Toxicological, pharmacological and clinical data
Traditional and complementary medicine
Traditional practitioners as primary health care workers
Traumatic or postoperative pain
Treating your patients
Treatment of STI-associated syndromes
Trends in drug utilization research in developing countries
Tuberculosis in the world of today

 
 Top of page
 

Contacts | E-mail scams | Employment | FAQs | Feedback | Privacy | RSS feeds
© WHO 2013
Last updated: May 3, 2013